Gilenya

Gilenya
Generic Name: fingolimod (fin GOE li mod)
Brand Names: Gilenya
Company: Novartis
FDA Approved: September 2010
Gilenya is rated 7.0/10

Gilenya (fingolimod) is an immunosuppressant. It works by keeping immune cells trapped in your lymph nodes so they can't reach the central nervous system (brain and spinal cord).

Gilenya dosing information
Usual Adult Dose for Multiple Sclerosis: 0.5 mg orally once daily

Comments: Monitor with first dose (see WARNINGS section).

Use: For the treatment of patients with relapsing forms of multiple sclerosis (MS) to reduce the frequency of clinical exacerbations and to delay the accumulation of physical disability.

Gilenya is used to treat relapsing multiple sclerosis (MS) in adults, and children and adolescents aged 10 years and older.

Gilenya will not cure MS, it will only decrease the frequency of relapse symptoms.

Important Information
You should not use Gilenya if you have a serious heart condition. This includes severe heart failure, "AV block," sick sinus syndrome (unless you have a pacemaker), taking certain heart rhythm medicines, or a recent heart attack, stroke, chest pain, or other serious heart problem.

Fingolimod can slow your heart rate. You will receive your first dose in a hospital setting where your heart rhythm can be monitored.

Gilenya affects your immune system. You may get infections more easily, even serious or fatal infections. Call your doctor if you have a fever, chills, aches, tiredness, vomiting, confusion, neck stiffness, increased sensitivity to light, or problems with speech, thought, vision, or muscle movement.